Login / Signup

Therapeutic success of sodium thiosulfate in treating cutaneous calciphylaxis in a patient with hyperphosphataemic familial tumoral calcinosis.

Sheila Requena LópezJorge Santos-JuanesPatricia MoralesCarlos Gómez
Published in: The Australasian journal of dermatology (2021)
Calciphylaxis is a potencially disorder in patients with hyperphosphatemic familial tumoral calcinosis (HFTC). Patients commonly present livedo racemosa and retiform purpura, which may progress to necrosis and very painful ulcers. Treatment with sodium thiosulfate provides good results; however, intralesional and intravenous treatment can be limited by its adverse effects. Topical sodium thiosulfate has been successfully reported for cutaneous calcification associated with connective tissue diseases and calciphylaxis in patients with chronic kidney disease. We provide a case report of a patient with HFTC and calciphylaxis who was treated with topical sodium thiosulfate with a rapid and complete response with no side effects.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • case report
  • ejection fraction
  • early onset
  • prognostic factors
  • low dose
  • combination therapy
  • quantum dots
  • smoking cessation